
Please try another search
HBM Holdings Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally. It develops the Harbour Mice Platform, which generates human monoclonal antibodies in two heavy and two light chain H2L2 and heavy chain formats. The company is developing Batoclimab (HBM9161), a human monoclonal antibody that selectively binds and inhibits the neonatal fragment crystallizable receptor for treating myasthenia gravis; Porustobart HBM4003, a human anti-CTLA-4 antibody against cytotoxic T-lymphocyte-associated antigen-4 for treating melanoma, colorectal cancer, hepatocellular carcinoma, and neuroendocrine neoplasm. It is also developing HBM7020 for treating hematologic carcinoma and autoimmune diseases; HBM9378 for the treatment of asthma and chronic obstructive pulmonary disease; and HBM1020, HBM1022, HBM9014, HBM7022, HBM7008, HBM9027, HBM7004, and HBM9033 for treating solid tumors. The company was incorporated in 2016 and is based in Suzhou, the People’s Republic of China.
Name | Age | Since | Title |
---|---|---|---|
Jon Marc Wigginton | - | 2020 | Member of Scientific Advisory Board |
Xiaoping Ye | 62 | 2020 | Independent Non-Executive Director |
Yiping Rong | 47 | 2022 | Chief Scientific Officer & Executive Director |
Peter F. Moesta | - | - | Member of Scientific Advisory Board & Chief CMC Advisor |
Robert A. Kramer | - | 2016 | Member of Scientific Advisory Board |
Frank Grosveld | - | 2016 | Member of Scientific Advisory Board |
Jingsong Wang | 60 | 2016 | Founder, Chairman & CEO |
Robert Irwin Kamen | 81 | 2016 | Independent Non-Executive Director & Member of Scientific Advisory Board |
Albert R. Collinson | 66 | 2023 | Independent Non-Executive Director |
Weiwei Chen | 59 | 2020 | Senior Business Adviser & Independent Non-Executive Director |
Zhigang Tian | - | 2020 | Member of Scientific Advisory Board |
Jon Marc Wigginton | 63 | 2020 | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review